Bolt Biotherapeutics, Inc.
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2020 | — | -21,290.9% | -26,289.2% |
| FY2021 | — | -7,364.1% | -7,824.7% |
| FY2022 | — | -1,576.6% | -1,537.8% |
| FY2023 | — | -967.4% | -878.6% |
| FY2024 | — | -949.9% | -820.8% |
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2020 | — | -21,290.9% | -26,289.2% |
| FY2021 | — | -7,364.1% | -7,824.7% |
| FY2022 | — | -1,576.6% | -1,537.8% |
| FY2023 | — | -967.4% | -878.6% |
| FY2024 | — | -949.9% | -820.8% |